CALANDRA BUONAURA, Sebastiano
 Distribuzione geografica
Continente #
NA - Nord America 17.885
AS - Asia 8.701
EU - Europa 7.468
SA - Sud America 1.254
AF - Africa 174
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 13
Totale 35.508
Nazione #
US - Stati Uniti d'America 17.623
SG - Singapore 3.210
GB - Regno Unito 2.552
CN - Cina 2.158
IT - Italia 1.578
HK - Hong Kong 970
BR - Brasile 963
VN - Vietnam 820
SE - Svezia 773
DE - Germania 560
FI - Finlandia 371
BD - Bangladesh 355
FR - Francia 346
UA - Ucraina 341
RU - Federazione Russa 329
KR - Corea 221
TR - Turchia 215
IN - India 204
BG - Bulgaria 141
ID - Indonesia 114
CA - Canada 110
NL - Olanda 110
AR - Argentina 94
MX - Messico 82
IE - Irlanda 72
IQ - Iraq 68
JP - Giappone 53
BE - Belgio 51
ZA - Sudafrica 50
PK - Pakistan 49
PL - Polonia 46
EC - Ecuador 41
AE - Emirati Arabi Uniti 39
CL - Cile 38
CO - Colombia 38
ES - Italia 38
AT - Austria 26
CZ - Repubblica Ceca 26
SA - Arabia Saudita 23
KE - Kenya 22
VE - Venezuela 21
EG - Egitto 20
MA - Marocco 20
TN - Tunisia 20
UZ - Uzbekistan 20
PY - Paraguay 18
BZ - Belize 17
CH - Svizzera 17
DZ - Algeria 17
IR - Iran 17
MY - Malesia 17
LT - Lituania 16
PE - Perù 16
UY - Uruguay 16
JO - Giordania 14
BA - Bosnia-Erzegovina 13
PH - Filippine 13
TW - Taiwan 12
AU - Australia 11
OM - Oman 11
PT - Portogallo 11
AZ - Azerbaigian 10
KZ - Kazakistan 10
NP - Nepal 10
RO - Romania 9
TH - Thailandia 9
BH - Bahrain 8
BO - Bolivia 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
EU - Europa 8
IL - Israele 8
JM - Giamaica 7
AL - Albania 6
ET - Etiopia 6
KG - Kirghizistan 6
KW - Kuwait 6
TT - Trinidad e Tobago 6
DK - Danimarca 5
HU - Ungheria 5
LB - Libano 5
SK - Slovacchia (Repubblica Slovacca) 5
GR - Grecia 4
GT - Guatemala 4
PR - Porto Rico 4
SV - El Salvador 4
SY - Repubblica araba siriana 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
EE - Estonia 3
GE - Georgia 3
HN - Honduras 3
HR - Croazia 3
LK - Sri Lanka 3
NG - Nigeria 3
PS - Palestinian Territory 3
QA - Qatar 3
RS - Serbia 3
SN - Senegal 3
AO - Angola 2
Totale 35.469
Città #
Singapore 2.107
Southend 1.865
Ashburn 1.809
Fairfield 1.752
Santa Clara 1.616
Woodbridge 1.212
Houston 1.005
Hong Kong 952
San Jose 858
Hefei 769
Chandler 751
Jacksonville 745
Seattle 700
Wilmington 615
Ann Arbor 610
Cambridge 560
Nyköping 458
Dearborn 445
London 372
Beijing 328
Ho Chi Minh City 271
Council Bluffs 269
Los Angeles 262
Helsinki 253
Seoul 218
The Dalles 216
Modena 209
Milan 203
Chicago 194
New York 193
Hanoi 192
San Diego 153
Princeton 148
Sofia 134
Lauterbourg 118
Eugene 115
Buffalo 113
Rome 107
Moscow 104
Shanghai 94
Dallas 90
Des Moines 89
São Paulo 89
Izmir 88
Columbus 86
Grafing 82
Salt Lake City 79
Jakarta 78
Dublin 70
Munich 59
Naples 58
Da Nang 56
Orem 54
Falls Church 49
Rio de Janeiro 44
Boardman 42
Brussels 41
Tokyo 41
Atlanta 40
Bremen 38
Elk Grove Village 38
Tampa 37
Bologna 36
Frankfurt am Main 33
Warsaw 33
Toronto 32
Mexico City 28
Redwood City 28
Belo Horizonte 27
Norwalk 27
Brooklyn 26
Guangzhou 26
Nuremberg 26
Santiago 26
Chennai 25
Phoenix 24
Turin 24
Baghdad 23
Montreal 23
Nanjing 23
Haiphong 22
Johannesburg 22
San Mateo 22
San Francisco 21
Brno 20
Detroit 20
Kent 20
Miano 20
Manchester 19
Poplar 19
St Louis 19
Boston 18
Kunming 18
Tashkent 18
Verona 18
Amsterdam 17
Augusta 17
Belize City 17
Biên Hòa 17
Brasília 17
Totale 25.314
Nome #
CASO CLINICO: QUANDO LA RISPOSTA ALLA DIETA IPOLIPIDEMIZZANTE DETERMINA LA DIAGNOSI 1.172
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 530
Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease 406
A 'de novo' point mutation of the low-density lipoprotein receptor gene in an Italian subject with primary hypercholesterolemia 379
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 371
Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia 366
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia 365
Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene 359
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 354
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 351
A novel deletion of BRCA1 gene that eliminates the ATG initiation codon without affecting the promoter region 351
A study of fatty liver disease and plasma lipoproteins in a kindred with familial hypobetalipoproteinemia due to a novel truncated form of apolipoprotein B (apo B-54.5) 350
Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy 348
Altered mRNA splicing in lipoprotein disorders 345
Novel mutations in SAR1B and MTTP genes in Tunisian children with chylomicron retention disease and abetalipoproteinemia. 339
A novel homozygous mutation in CETP gene as a cause of CETP deficiency in a caucasian kindred 338
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 338
An apparent inconsistency in parent to offspring transmission ofpoint mutations of LDLR gene in familial hypercholesterolemia 330
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2+5G > C mutation in ABCA1 gene 330
Adaptor protein ARH is recruited to the plasma membrane by low density lipoprotein (LDL) binding and modulates endocytosis of the LDL/LDL receptor complex in hepatocytes 325
Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene 321
Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride. 320
MOLECULAR CHARACTERIZATION OF TWO PATIENTS WITH SEVERE LCAT DEFICIENCY 318
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia 317
A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease. 316
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 315
Identification and characterization of novel loss of function mutations in ATP-binding cassette transporter A1 in patients with low plasma high-density lipoprotein cholesterol. 315
Absence of apolipoprotein B-48 in the chick, Gallus domesticus 313
Impact of rare variants in autosomal dominant hypercholesterolemia causing genes. 308
A novel mutation in the sterol 27-hydroxylase gene of a woman with autosomal recessive cerebrotendinous xanthomatosis. 300
Multiple abnormally spliced ABCA1 mRNAs caused by a novel splice site mutation of ABCA1 gene in a patient with Tangier disease. 299
Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients 298
Plasma and urine lipoproteins during the development of nephrotic syndrome induced in the rat by adriamycin. 297
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease 296
APOA5 and trigliceride metabolism, lesson from human APOA5 deficiency. 295
Hypobetalipoproteinemia with an apparently recessive inheritance due to a de novo mutation of apolipoprotein B 294
Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia. 291
Denaturing high-performance liquid chromatography in the detection of ABCA1 gene mutations in familial HDL deficiency 290
Preemptive liver transplantation in a child with familial hypercholesterolemia 290
Modulation of the synthesis of apolipoproteins in rat hepatoma cells. 287
Functional lecithin: Cholesterol acyltransferase Is not required for efficient atheroprotection in humans 286
Separation of the isoprotein forms of apoprotein A-I of rat, rabbit and human HDL by combined isoelectrofocusing and SDS-polyacrylamide gel electrophoresis. 285
Sequential expression during postnatal development of specific markers of junctional and free sarcoplasmic reticulum in chicken pectoralis muscle. 281
Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia. 281
A 3-day-old neonate with severe hypertriglyceridemia from novel mutations of the GPIHBP1 gene 281
Severe HDL deficiency due to novel defects in the ABCA1 transporter 280
Rearrangements of the ABCC6 gene in Italian patients with PXE 279
Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): A phenotypic comparison 278
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia 275
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 275
Effect of the desulfation of heparin on its anticoagulant and anti-proliferative activity 274
Molecular diagnosis of hypobetalipoproteinemia: an ENID Review 274
Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian Patients: Identification and structural modeling of novel mutations 271
Isoforms of rat apolipoprotein A-I isolated from the lipoproteins of hepatic Golgi apparatus and plasma. 270
Adult-onset Niemann-Pick type C disease: A clinical, neuroimaging, and molecular genetic study 268
Apolipoprotein B-100 production and cholesteryl ester content in the liver of developing chick 265
Analysis of LDL receptor gene mutations in Italian patients with homozygous familial hypercholesterolemia 265
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia 265
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders 265
Effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome 263
Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene 260
Cholesterol synthesis in isolated rat hepatocytes: effect of homologous and heterologous serum lipoproteins. 260
Quantitative polymerase chain reaction and microchip electrophoresis to detect major rearrangements of the low-density lipoprotein receptor gene causing familial hypercholesterolemia 259
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 256
Genetic polymorphisms affecting the phenotypic expression of familial hypercholesterolemia 254
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. 253
Fatty liver in heterozygous hypobetalipoproteinemia caused by a novel truncated form of apolipoprotein B 252
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations 252
Characterization of three mutations of the low density lipoprotein receptor gene in Italian patients with familial hypercholesterolemia. 251
Characterization of Three Kindreds with Familial Combined Hypolipidemia Due to Loss of Function Mutations of ANGPTL3. 249
Changes of the main isoform of human apolipoprotein A-I following incubation of plasma. 244
A large deletion in the LDL receptor gene--the cause of familial hypercholesterolemia in three Italian families: a study that dates back to the 17th century (FH-Pavia 243
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 242
Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney 239
β-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia 239
Pravastatin in heterozygous familial hypercholesterolemia: low-density lipoprotein (LDL) cholesterol-lowering effect and LDL receptor activity on skin fibroblastS. 239
Partial duplication of the EGF precursor homology domain of the LDL receptor protein causing familial hypercholesterolemia (FH-Salerno) 237
Severe hypertriglyceridemia in a newborn with monogenic lipoprotein lipase deficiency: an unconventional therapeutic approach with exchange transfusion. 237
Lung involvement in Niemann-Pick disease type C1: improvement with bronchoalveolar lavage 235
Plasma lipoproteins in rats with experimental biliary obstruction. II. An ultrastructural study. 235
Genetics and molecular biology: proprotein convertase subtilisin/kexin type 9 and LDL receptor--an intriguing story. 234
Heavy metals and experimental atherosclerosis. Effect of lead intoxication on rabbit plasma lipoproteins. 231
Duplication of exons 13, 14 and 15 of the LDL-receptor gene in a patients with heterozygous familial hypercholesterolemia 229
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 229
Secretion of lipoproteins, apolipoprotein A-I and apolipoprotein E by isolated and perfused liver of rat with experimental nephrotic syndrome. 226
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 223
Synthesis and secretion of apolipoprotein A-I by chick skin. 223
Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside: hepatic synthesis of lipoproteins and apolipoproteins. 222
Plasma and urinary lipids and lipoproteins during the development of nephrotic syndrome induced in the rat by puromycin aminonucleoside. 219
Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia 219
Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs). 218
Synthesis and secretion of B-100 and A-I apolipoproteins in response to the changes of intracellular cholesteryl ester content in chick liver 217
Isolation of a cDNA clone for chick intestinal apolipoprotein AI (Apo-AI) and its use for detecting apo-AI mRNA expression in several chick tissues. 217
Changes in apolipoprotein A-I mRNA level in the liver of rats with experimental nephrotic syndrome 217
Cholesterol synthesis in freshly isolated human leukocytes. 212
The complete sequence of chick apolipoprotein AI mRNA and its expression in the developing chick 211
The molecular basis of lecithin: Cholesterol acyltransferase deficiency syndromes: A comprehensive study of molecular and biochemical findings in 13 unrelated Italian families 210
Phenotypic expression of heterozygous familial hypobetalipoproteinemia in three kindreds with novel mutations of apolipoprotein B gene 209
Plasma lecithin: cholesterol acyltransferase activity in liver disease. 207
Plasma lipoproteins in rats with experimental biliary obstruction. I. A chemical study. 207
Totale 28.924
Categoria #
all - tutte 135.349
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.349


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021150 0 0 0 0 0 0 0 0 0 0 0 150
2021/20222.677 109 307 317 155 55 210 204 103 284 178 494 261
2022/20232.390 258 267 163 197 285 383 37 213 324 53 99 111
2023/20241.564 66 78 144 141 292 162 150 162 56 90 40 183
2024/20256.147 196 52 118 406 1.129 968 592 340 534 191 712 909
2025/202611.732 788 548 973 1.144 1.925 810 1.520 595 993 1.195 758 483
Totale 35.662